Skip to main content
Livermore
Livermore
ZHEN

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

UTHR holding history

United Therapeutics Corp in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

UTHR overviewAll 13F holders of UTHRFull Q2 2026 holdings

Shares (Q2 2026)
9,855
Value
$5.34M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of UTHR by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,855$5.34M<0.1%−1,398−12.4%ReducedHolders
Q1 202611,253$6.67M<0.1%−1,056−8.6%ReducedHolders
Q4 202512,309$6.00M<0.1%+2,872+30.4%AddedHolders
Q3 20259,437$3.96M<0.1%+1,744+22.7%AddedHolders
Q2 20257,693$2.21M<0.1%+964+14.3%AddedHolders
Q1 20256,729$2.07M<0.1%+3,278+95.0%AddedHolders
Q4 20243,451$1.22M<0.1%−10.0%ReducedHolders
Q3 20243,452$1.24M<0.1%+124+3.7%AddedHolders
Q2 20243,328$1.06M<0.1%−44−1.3%ReducedHolders
Q1 20243,372$774.5K<0.1%−3,090−47.8%ReducedHolders
Q4 20236,462$1.42M<0.1%+568+9.6%AddedHolders
Q3 20235,894$1.33M<0.1%−3,330−36.1%ReducedHolders
Q2 20239,224$2.04M<0.1%−4,967−35.0%ReducedHolders
Q1 202314,191$3.18M<0.1%−151,652−91.4%ReducedHolders
Q4 2022165,843$46.1M0.2%−1,547−0.9%ReducedHolders
Q3 2022167,390$35.0M0.2%+27,467+19.6%AddedHolders
Q2 2022139,923$33.0M0.2%+118,733+560.3%AddedHolders
Q1 202221,190$3.80M<0.1%−153−0.7%ReducedHolders
Q4 202121,343$4.61M<0.1%+6,292+41.8%AddedHolders
Q3 202115,051$2.78M<0.1%+11,925+381.5%AddedHolders
Q2 20213,126$561.0K<0.1%+39+1.3%AddedHolders
Q1 20213,087$516.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.